Comparative Study on Associations Between Lung Cancer Prognosis and Diagnostic Criteria Set by the European Palliative Care Research Collaboration and the Asian Working Group for Cachexia
- PMID: 39654007
- PMCID: PMC11735465
- DOI: 10.1111/1759-7714.15503
Comparative Study on Associations Between Lung Cancer Prognosis and Diagnostic Criteria Set by the European Palliative Care Research Collaboration and the Asian Working Group for Cachexia
Abstract
Background: Cachexia is a poor prognostic factor in many advanced cancers. Cachexia diagnostic criteria of the European Palliative Care Research Collaboration (EPCRC) may underestimate cachexia in Asians; therefore, new criteria have been proposed by the Asian Working Group for Cachexia (AWGC). We compared both criteria to determine differences in diagnostic rates and their association with lung cancer prognosis.
Patients and methods: This single-center, retrospective cohort study considered lung cancer outpatients receiving chemotherapy. Survival was analyzed using Kaplan-Meier curves and log-rank tests. The association between cachexia diagnosis and prognosis was examined for each set of criteria using a Cox proportional hazards model. C-statistic analysis was performed to compare the discriminative power for prognosis.
Results: Among the 106 participants analyzed (median age, 75 [71-79] years; 75 males [70.8%]; 91 [85.9%] with performance status [PS] 0-1), 58 (54.7%) and 77 (72.6%) cachexia cases were diagnosed using the EPCRC and AWGC criteria, respectively. The latter encompassed all but one patient diagnosed using the EPCRC criteria. Patients with cachexia had a significantly poorer prognosis according to both criteria (EPCRC, p = 0.002; AWGC, p = 0.001). Both criteria had almost equal discriminative power for prognosis (EPCRC, C-statistic = 0.658; AWGC, C-statistic = 0.658). CRP in the AWGC criteria was most strongly related to prognosis.
Conclusions: Cachexia was an independent poor prognostic factor in lung cancer patients receiving chemotherapy under the AWGC and EPCRC criteria, both of which had similar prognostic discriminatory power. Among CRP, anorexia, and grip strength, elevated CRP may be the most prognostically relevant parameter in the AWGC criteria.
Keywords: cancer cachexia; lung cancer; new cachexia diagnostic criteria for Asians; prognosis.
© 2024 The Author(s). Thoracic Cancer published by John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Cancer cachexia onset and survival outcomes in metastatic colorectal cancer: Comparative assessment of the asian working group for cachexia and the European palliative care research collaborative criteria, and utility of modified glasgow prognostic score.Int J Colorectal Dis. 2025 Jul 25;40(1):164. doi: 10.1007/s00384-025-04962-2. Int J Colorectal Dis. 2025. PMID: 40715550 Free PMC article.
-
Validity of the diagnostic criteria from the Asian Working Group for Cachexia in advanced cancer.J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):370-379. doi: 10.1002/jcsm.13408. Epub 2023 Dec 19. J Cachexia Sarcopenia Muscle. 2024. PMID: 38115133 Free PMC article.
-
Impacts of fluid retention on prognostic abilities of cachexia diagnostic criteria in cancer patients with refractory cachexia.Clin Nutr ESPEN. 2024 Apr;60:373-381. doi: 10.1016/j.clnesp.2024.02.026. Epub 2024 Feb 29. Clin Nutr ESPEN. 2024. PMID: 38479937
-
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia.J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):1949-1958. doi: 10.1002/jcsm.13323. Epub 2023 Sep 5. J Cachexia Sarcopenia Muscle. 2023. PMID: 37667992 Free PMC article. Review.
-
[Overview of Cancer-Associated Cachexia].Gan To Kagaku Ryoho. 2019 Dec;46(12):1814-1817. Gan To Kagaku Ryoho. 2019. PMID: 31879394 Review. Japanese.
Cited by
-
Cancer cachexia onset and survival outcomes in metastatic colorectal cancer: Comparative assessment of the asian working group for cachexia and the European palliative care research collaborative criteria, and utility of modified glasgow prognostic score.Int J Colorectal Dis. 2025 Jul 25;40(1):164. doi: 10.1007/s00384-025-04962-2. Int J Colorectal Dis. 2025. PMID: 40715550 Free PMC article.
References
-
- Evans W. J., Morley J. E., Argilés J., et al., “Cachexia: A New Definition,” Clinical Nutrition 27 (2008): 793–799. - PubMed
-
- Fearon K., Arends J., and Baracos V., “Understanding the Mechanisms and Treatment Options in cancer cachexia,” Nature Reviews. Clinical Oncology 10 (2013): 90–99. - PubMed
-
- Argilés J. M., Busquets S., Stemmler B., and López‐Soriano F. J., “Cancer Cachexia: Understanding the Molecular Basis,” Nature Reviews. Cancer 14 (2014): 754–762. - PubMed
-
- Roeland E. J., Bohlke K., Baracos V. E., et al., “Management of Cancer Cachexia: ASCO Guideline,” Journal of Clinical Oncology 38 (2020): 2438–2453. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous